Proposal of Membrane Transport Mechanism of Protein-Unbound Ulifloxacin into Epithelial Lining Fluid Determined by Improved Microdialysis(Biopharmacy)
スポンサーリンク
概要
- 論文の詳細を見る
Microdialysis method (MD) is useful for sampling protein-unbound substances in vivo. Generally in the MD, a reference compound is used to correct differences in drug permeation clearance through a dialysis membrane in vivo and in vitro. No reference compound was, however, used for determination of a protein-unbound drug concentration in the epithelial lining fluid (ELF). In this study, we firstly examined the propriety of endogenous urea as a reference compound to determine the protein-unbound ulifloxacin concentrations in rat ELF by MD. Endogenous urea was used to correct differences in the permeation clearance in vivo and in vitro which reflect the differences in the extent of contact between a tip probe and ELF in vivo and in vitro. The results showed that our MD is applicable to determine the various concentrations of ulifloxacin and urea, and that we can use endogenous urea as a reference compound even if the extent of the contact between a tip of the probe and the ELF is small. In addition, use of urea concentrations does not affect drug distribution from plasma to ELF because we used endogenous urea. These results support usefulness of endogenous urea as a reference compound to determine protein-unbound drug concentration in ELF by MD. In addition, our results also suggest the existence of certain distribution mechanisms which cause the high penetration ulifloxacin into ELF. Our MD can help progress in pharmacokinetic-pharmacodynamic analysis of various antibiotics in the case where the concentrations in ELF are not equal to that in plasma.
- 2008-09-01
著者
-
AOKI Makoto
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
IGUCHI Maki
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
HAYASHI Hiroyuki
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
SUZUKI Hisashi
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
SHIBASAKI Shigeki
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
KUROSAWA Tohru
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
HAYASHI Masahiro
School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
-
SUZUKI HISASHI
Meiji Seika Kaisha, Ltd., Applied Pharmacology Research Labs., Pharmaceutical Research Center
-
SHIBASAKI SHIGEKI
Meiji Seika Kaisha, Ltd., Applied Pharmacology Research Labs., Pharmaceutical Research Center
-
KUROSAWA TOHRU
Meiji Seika Kaisha, Ltd., Applied Pharmacology Research Labs., Pharmaceutical Research Center
-
Suzuki Hisashi
Meiji Seika Kaisha Ltd. Applied Pharmacology Research Labs. Pharmaceutical Research Center
-
Hayashi Masahiro
School Of Pharmacy Tokyo University Of Pharmacy And Life Science
-
Shibasaki Shigeki
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha Ltd.
-
Hayashi Hiroyuki
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha Ltd.
-
Iguchi Maki
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha Ltd.
-
Kurosawa Tohru
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha Ltd.
-
Aoki Makoto
Applied Pharmacology Research Laboratories, Pharmaceutical Research Center, Meiji Seika Kaisha Ltd.
関連論文
- Proposal of Membrane Transport Mechanism of Protein-Unbound Ulifloxacin into Epithelial Lining Fluid Determined by Improved Microdialysis(Biopharmacy)
- Prulifloxacin (PUFX) の肝臓への取り込み機構の解明
- Bile Acid-Induced Elevated Oxidative Stress in the Absence of Farnesoid X Receptor(Biochemistry)
- Active Uptake of Ulifloxacin from Plasma to Lung That Controls Its Concentration in Epithelial Lining Fluid
- A new concept and a theoretical consideration of the mechanism-based pharmacokinetics/pharmacodynamics (PK/PD) modeling for antimicrobial agents
- Breaking Through the Stage of Non-clinical to Clinical in the Drug Development Process(Breaking Through the Stage of Non-clinical to Clinical in the Drug Development Process, Proceedings of the 32nd Annual Meeting)
- Comparative Analysis of In Vitro and In Vivo Pharmacokinetic Parameters Related to Individual Variability of GTS-21 in Canine
- P8-36 Evaluation of angialgia with flexion reflex in a rabbit model(STATISTICAL AND TEST METHODS/LOCAL STIMURATION)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- 耳鼻科領域感染症及び肺炎の小児患者における新規経口カルバペネム剤テビペネム・ピボキシルの母集団薬物動態解析
- The Effects of Emulsifying Agents on Disposition of Lipid-Soluble Drugs Included in Fat Emulsion